Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lauren Nardella

Lauren Nardella covers health care business topics, including contributions for more than a decade to HBW Insight (and previously the Rose Sheet) for more than a decade, where’s she has covered the regulation, business, science and policy of the cosmetics and personal-care products industries. She enjoys tackling complex issues and turning them into stories that help readers stay abreast of current topics. Nardella was previously a business reporter for various daily newspapers. She lives in Northern Virginia.

Latest From Lauren Nardella

USDA’s New Rule To Strengthen Organic Enforcement Falls Short Of Cosmetics Solution

The Organic Trade Association expects the USDA final rule to “protect organic integrity throughout the supply chain,” promote consumer trust, and incentivize cosmetics brands to seek certification under a more robust National Organic Program. But foundational problems linked to alleged organic deception in beauty and personal care still exist.

Regulation Advertising, Marketing & Sales

US FDA Catches Up On Monograph Petitions: Denies Antiseptic TFM Requests Made In 2001

Agency’s recent responses denying three petitions filed in 2001 by US industry trade groups and in 2002 by pharmaceutical ingredient and chemicals firm explain the changes requested can be proposed in “OTC monograph order requests” pathway established in program overhaul.


Root Wellness Provides Update Following Self-Regulatory Case That Resulted In FTC Referral

Root Wellness execs address the company’s scrape with the Direct Selling-Self Regulatory Council and resulting referral to the Federal Trade Commission.

Advertising, Marketing & Sales Regulation

States’ Restrictions On Sales Of Weight Loss OTCs, Supplements Stalled By Vetoes, Lobbying

States’ efforts on prohibiting sales to minors of OTC diet drugs as well as weight loss and bodybuilding supplements to minors didn’t advance in 2022, setting stage for more showdowns in 2023.

Dietary Supplements OTC Drugs

EU Court Shoots Down TiO2 Hazard Classification, Opening Door For Future Challenges

Titanium dioxide stakeholders argued successfully in the Court of Justice of the European Union that TiO2’s hazard classification in 2020 under the CLP was based on shoddy science and a flawed interpretation of EU law. The industry win comes as the European Commission is finalizing a regulation to establish new CLP hazard classes, including for endocrine disruptors.

Europe Legal Issues

Cosmetics Reform In, Dietary Supplements Out Of US Omnibus Spending Bill

The must-pass federal spending bill includes the Modernization of Cosmetics Regulation Act, which previously appeared as a rider in US Food and Drug Administration user-fee legislation but was cut from the final iteration.

Legislation FDA
See All